Open
SectorHealthcare
31.06 -0.64
24h
Min
30.52
Max
31.36
Income | -27M -12M |
---|---|
Sales | -24M 150M |
P/E Sector Avg | 29.081 50.291 |
EPS | 0.436 |
Profit margin | -7.894 |
Employees | 674 |
EBITDA | -27M 18M |
Recommendations | Buy |
---|---|
12 Months Forecast | +25% upside |
Next Earnings | 5 sie 2025 |
---|
Market Cap | -345M 1.8B |
---|---|
Previous open | 31.7 |
Previous close | 31.06 |
By Acuity
50%
50%
154 / 380 Ranking in Healthcare
By Trading Central
Confidence
Weak Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 39 USD 25%
High 45 USD
Low 36 USD
Based on 3 Wall Street analysts offering 12 month price targets forSupernus Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$